Skip to content

Clinical trials

Completed Lung Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Completed Country / region: Norway Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20071
20103
20111
20121
20132
20141
20152
20161
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Oslo University Hospital3
Norwegian University of Science and Technology2
Ariad Pharmaceuticals1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Gustave Roussy, Cancer Campus, Grand Paris1
Haukeland University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms19
Carcinoma, Non-Small-Cell Lung9
Adenocarcinoma of Lung4
Melanoma2
Neoplasm Metastasis2
Adenocarcinoma1
Brain Neoplasms1
Breast Neoplasms1
Carcinoma1
Carcinoma, Large Cell1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.